mHealth Intervention to Support Self-care During the Hospital to Home Transition in Individuals With Heart Failure
HF-mHealth
Evaluation of the Feasibility, Usability, and Preliminary Effects of an mHealth Intervention Complementary to Usual Care in Individuals With Heart Failure: Protocol for a Pilot Randomized Clinical Trial
1 other identifier
interventional
30
1 country
1
Brief Summary
This study is a pilot randomized controlled trial designed to evaluate the feasibility, acceptability, usability, and preliminary efficacy of a mobile health (mHealth) educational self-management intervention for individuals with heart failure during the transition from hospital to home. Participants will be randomly assigned in a 1:1 ratio to receive either usual care alone or usual care plus the mHealth intervention. The mobile application is designed to support heart failure self-care through tailored educational content, symptom self-monitoring, automated feedback, behavioral reinforcement messages, caregiver involvement, and secure communication with the healthcare team. The application is educational in nature and does not replace standard medical treatment. A total of 30 participants will be enrolled and followed for 60 days after hospital discharge, with outcome assessments conducted at 30 and 60 days. Primary outcomes focus on feasibility, technology acceptance, and usability of the intervention. Secondary exploratory outcomes include changes in self-care behaviors, functional status, heart failure related hospital readmissions and natriuretic peptide levels. Results from this pilot study will inform the design of a future definitive randomized controlled trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable heart-failure
Started Mar 2026
Shorter than P25 for not_applicable heart-failure
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 19, 2026
CompletedStudy Start
First participant enrolled
March 1, 2026
CompletedFirst Posted
Study publicly available on registry
March 17, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2027
March 20, 2026
March 1, 2026
1.3 years
February 19, 2026
March 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Recruitment rate
Proportion of eligible participants who are enrolled and randomized in the trial
From screening until completion of recruitment
Retention rate
Proportion of randomized participants who complete follow-up assessments
30 and 60 days post-discharge
Adherence to the mHealth intervention
Proportion of educational modules completed and symptom self-monitoring entries recorded in the application logs.
30 and 60 days post-discharge
Data completeness
Percentage of completed outcome assessments among enrolled participants
30 and 60 days post-discharge
Time required for enrollment and intervention delivery
Time required to complete enrollment procedures and initial intervention delivery, measured in minutes.
At enrollment
Secondary Outcomes (3)
Technology Acceptance of the Mobile Application (TAM)
60 days post-discharge
Usability of the Mobile Application
30 days post-discharge
Change in Self-Care (SCHFI v7.2)
Baseline, 30 days and 60 days post-discharge
Other Outcomes (3)
Heart Failure Related Hospital Readmissions
30 and 60 days post-discharge
Change in NYHA Functional Class
Baseline, 30 days and 60 days post-discharge
Change in NT-proBNP Levels
Baseline, 30 days and 60 days post-discharge
Study Arms (2)
Usual Care
ACTIVE COMPARATORParticipants will receive standard hospital to home transitional care, including multidisciplinary discharge education, medication reconciliation, and scheduled outpatient follow-up according to institutional protocols.
mHealth educational self-management intervention
EXPERIMENTALParticipants will receive a mobile health (mHealth) educational self-management intervention in addition to usual care. The intervention consists of a mobile application designed to support heart failure self-care through tailored educational modules, symptom self-monitoring, automated feedback, behavioral reinforcement messages, caregiver integration, and secure communication with the healthcare team over a 60-day period following hospital discharge.
Interventions
A structured mobile health educational and self-management intervention delivered through a smartphone application. The intervention provides tailored heart failure education, daily and weekly symptom monitoring, automated reinforcement messages, caregiver engagement tools, and communication support with the healthcare team. The intervention is educational in nature and does not function as a regulated medical device.
Standard multidisciplinary hospital discharge education, medication reconciliation, and scheduled outpatient follow-up provided according to institutional protocols.
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years
- Diagnosis of heart failure (NYHA Class II or III)
- Clinically stable at discharge (no IV inotropes within 48 hours; hemodynamically stable)
- Ownership of compatible smartphone (Android/iOS)
- Basic digital literacy
- Availability of informal caregiver willing to support the process
You may not qualify if:
- Life expectancy \< 6 months
- Severe cognitive impairment (MMSE \<24 or documented dementia)
- Inability to provide informed consent
- Participation in another interventional study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centro Cardiovascular Colombiano SAS
Bogotá, Bogota D.C., 0907, Colombia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcome assessors will be blinded to group allocation. Due to the nature of the intervention, participants and care providers cannot be blinded.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 19, 2026
First Posted
March 17, 2026
Study Start
March 1, 2026
Primary Completion (Estimated)
June 1, 2027
Study Completion (Estimated)
June 1, 2027
Last Updated
March 20, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
- Time Frame
- Data will be available beginning 6 months after publication of the primary results and will remain available for a minimum of 5 years.
- Access Criteria
- Qualified researchers may request access by contacting the principal investigator. Requests must include a brief proposal, analysis plan, and a data use agreement. Data will be shared in a de-identified format through a secure institutional repository.
De-identified individual participant data will be shared, including demographic and baseline clinical variables, group assignment, feasibility outcomes, technology acceptance, usability measures, self-care outcomes, NYHA functional class, NT-proBNP levels, and heart failure-related readmissions. Data will be made available upon reasonable request from qualified investigators for academic and non-commercial research purposes.